• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】11021

【品名】Methanamine; Methylamine

【CA登记号】74-89-5

【 分 子 式 】CH5N

【 分 子 量 】31.05744

【元素组成】C 38.67% H 16.23% N 45.1%

与该中间体有关的原料药合成路线共 32 条

合成路线1

该中间体在本合成路线中的序号:(X)

Elinogrel potassium is prepared as follows. Condensation of methyl 2-amino-4,5-difluorobenzoate (I) with 4-nitrophenyl chloroformate (II) in refluxing CH2Cl2 gives the 4-nitrophenyl carbamate (III), which is condensed with 4-(Boc-amino)aniline (IV) in the presence of Et3N in THF at 60-70 °C to yield the diaryl urea (V), which, without isolation, is cyclized to the quinazoline-2,4-dione (VI) upon treatment with methanolic NaOMe or DBU. Alternatively, diaryl urea (V) is prepared by treatment of anthranilate (I) with COCl2 in toluene to yield isocyanate (VII) and/or carbamoyl chloride (VIII), which are then condensed with 4-(Boc-amino)aniline (IV) in the presence of Et3N in DMF . Deprotection of the amino group in compound (VI) by removal of the Boc group by means of HCl in dioxane provides 3-(4-aminophenyl)-6,7-difluoroquinazoline-2,4(1H,3H)-dione hydrochloride (IX), which undergoes selective fluoride displacement with methylamine (X) in DMSO at 110 °C to provide 3-(4-aminophenyl)-6-fluoro-7-(methylamino)quinazoline-2,4(1H,3H)-dione (XI). Subsequent carbamoylation of the primary amino group of quinazoline (XI) with ethyl N-(5-chlorothien-2-ylsulfonyl)carbamate (XII) in refluxing DMSO or acetonitrile yields elinogrel (XIII) , which is finally converted to its potassium salt by treatment with KOH in acetonitrile/H2O at 45-55 °C .

1 Scarborough, R.M., Pandey, A., Yiannikouros, G.P., Cruskie, M., White, D.C., Mehrotra, M. (Portola Pharmaceuticals, Inc.). Substituted-(quinazolinyl)phenyl thiophenyl-sulfonylureas, methods for making and intermediates thereof. US 2007208045, WO 2007056167.
2 Huang, W., Mehrotra, M., Zhang, X., Cannon, H., Grant, C.M. (Portola Pharmaceuticals, Inc.). [4-(6-Halo-7-substituted-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto. EP 1951254, JP 2009515836, US 2007123547, WO 200705619.
3 Sharp, E., Quegan, L.J., Pandey, A., Wang, J., Nieder, M., Huang, W. (Portola Pharmaceuticals, Inc.). [4-(6-Fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, in different crystalline forms, pharmaceutical compositions thereof. EP 2076510, JP 2010526105, WO 2008137809.
4 Sharp, E., Quegan, L.J., Pandey, A., Wang, J., Nieder, M., Huang, W. (Portola Pharmaceuticals, Inc.). [4-(6-Fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto. US 2009156620, WO 2010054020.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 69088 methyl 2-amino-4,5-difluorobenzoate;2-Amino-4,5-difluorobenzoicacid methyl ester 207346-42-7 C8H7F2NO2 详情 详情
(II) 16605 4-Nitrophenyl chloroformate; 1-[(Chlorocarbonyl)oxy]-4-nitrobenzene 7693-46-1 C7H4ClNO4 详情 详情
(III) 69089 methyl 4,5-difluoro-2-(((4-nitrophenoxy)carbonyl)amino)benzoate   C15H10F2N2O6 详情 详情
(IV) 43972 4-(N-Boc-aminomethyl)aniline;tert-butyl (4-aminophenyl)carbamate;tert-butyl 4-aminophenylcarbamate C11H16N2O2 详情 详情
(V) 69090 methyl 2-(3-(4-((tert-butoxycarbonyl)amino)phenyl)ureido)-4,5-difluorobenzoate   C20H21F2N3O5 详情 详情
(VI) 69091 tert-butyl (4-(6,7-difluoro-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)phenyl)carbamate   C19H17F2N3O4 详情 详情
(VII) 69092 methyl 4,5-difluoro-2-isocyanatobenzoate   C9H5F2NO3 详情 详情
(VIII) 69093 methyl 2-((chlorocarbonyl)amino)-4,5-difluorobenzoate   C9H6ClF2NO3 详情 详情
(IX) 69094 3-(4-aminophenyl)-6,7-difluoroquinazoline-2,4(1H,3H)-dione hydrochloride   C14H9F2N3O2.HCl 详情 详情
(X) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(XI) 69095 3-(4-aminophenyl)-6-fluoro-7-(methylamino)quinazoline-2,4(1H,3H)-dione   C15H13FN4O2 详情 详情
(XII) 69097 ethyl N-(5-chlorothien-2-ylsulfonyl)carbamate;[(5-Chlorothien-2-yl)sulfonyl]carbamic acid ethyl ester;Ethyl[(5-chlorothiophen-2-yl)sulfonyl]carbamate;N-[(5-chloro-2-thienyl)sulfonyl]- 849793-87-9 C7H8ClNO4S2 详情 详情
(XIII) 69096 5-chloro-N-((4-(6-fluoro-7-(methylamino)-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)phenyl)carbamoyl)thiophene-2-sulfonamide   C20H15ClFN5O5S2 详情 详情

合成路线2

该中间体在本合成路线中的序号:

3-Hydroxybenzaldehyde (I) was protected as the methoxyethoxymethyl ether derivative (II) by treatment with methoxyethoxymethyl chloride and diisopropyl ethyl amine. Subsequent condensation of (II) with dimethyloxosulfonium methylide, generated from oxosulfonium salt (III) and NaH, gave rise to the racemic epoxide (IV). Kinetic resolution by hydrolysis with (R,R)-N,N'-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt (III) acetate complex provided the (S)-diol (V) along with the unreacted (R)-epoxide (VI), which were separated by column chromatography. Opening of the desired (R)-epoxide (VI) with methanolic methylamine gave amino alcohol (VII). Finally, removal of the methoxyethoxymethyl group by refluxing in methanolic HCl furnished the title compound.

1 Gurjar, M.K.; et al.; A practical synthesis of (R)-(-)-phenylephrine hydrochloride. Org Process Res Dev 1998, 2, 6, 422.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
40670 2-(chloromethoxy)ethyl methyl ether; 1-(chloromethoxy)-2-methoxyethane; (2-methoxyethoxy)methyl chloride 3970-21-6 C4H9ClO2 详情 详情
(I) 28537 3-hydroxybenzaldehyde 100-83-4 C7H6O2 详情 详情
(II) 36802 3-[(2-methoxyethoxy)methoxy]benzaldehyde C11H14O4 详情 详情
(III) 29693 Trimethylsulfoxonium iodide 1774-47-6 C3H9IOS 详情 详情
(IV) 36803 (2-methoxyethoxy)methyl 3-(2-oxiranyl)phenyl ether; 2-[3-[(2-methoxyethoxy)methoxy]phenyl]oxirane C12H16O4 详情 详情
(V) 36804 (1S)-1-[3-[(2-methoxyethoxy)methoxy]phenyl]-1,2-ethanediol C12H18O5 详情 详情
(VI) 36805 (2-methoxyethoxy)methyl 3-[(2R)oxiranyl]phenyl ether; (2R)-2-[3-[(2-methoxyethoxy)methoxy]phenyl]oxirane C12H16O4 详情 详情
(VII) 36806 (1R)-1-[3-[(2-methoxyethoxy)methoxy]phenyl]-2-(methylamino)-1-ethanol C13H21NO4 详情 详情

合成路线3

该中间体在本合成路线中的序号:(V),(X)

2) The condensation of N,N-diphenylcarbamoyl chloride (IV) with [13C]-labeled methylamine (V) gives the corresponding urea (VI), which by heating at 240 C is converted to the [13C]-labeled methyl isocyanate (VII). Finally, this compound is cyclized with the diazonium salt (VIII) (obtained by diazotation of 3-aminopyrazole-4-carbonitrile with NaNO2-HCl in the usual way) to afford temozolomide labeled at the methyl in the 3-position. 3) The preceding sequence performed with [15N]-labeled methylamine (X) gives urea (XI), isocyanate (XII) and finally temozolomide labeled at the N in the 3-position.

1 Wilman, D.E.V.; Thomson, W.; Wheelhouse, R.T.; Stevens, M.F.G.; Antitumour imidazotetrazines. 31. The synthesis of isotopically labelled temozolomide and a multinuclear (H-1, C-13, N-15) magnetic resonance investigation of temozolomide and mitozolomide. J Chem Soc - Perkins Trans I 1995, 3, 3, 249.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VII),(XII) 11019 (Methylimino)(oxo)methane; methyl isocyanate C2H3NO 详情 详情
(V),(X) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(VI),(XI) 11022 1-Methyl-3,3-diphenylurea; N'-Methyl-N,N-diphenylurea 13114-72-2 C14H14N2O 详情 详情
(IV) 11020 N,N-Diphenylcarbamic chloride; Diphenylcarbamyl chloride 83-01-2 C13H10ClNO 详情 详情
(V) 45041 methylamine; methanamine CH5N 详情 详情
(VI) 45042 N'-methyl-N,N-diphenylurea C14H14N2O 详情 详情
(VII) 45043 (methylimino)(oxo)methane; methyl isocyanate C2H3NO 详情 详情
(VIII) 11016 1-[5-(Aminocarbonyl)-4-imidazolidinyl]diazonium C4H3N5O 详情 详情
(IX) 11015 5-Amino-1H-imidazole-4-carboxamide 360-97-4 C4H6N4O 详情 详情
(X) 45044 methylamine; methanamine CH5N 详情 详情
(XI) 45045 N'-methyl-N,N-diphenylurea C14H14N2O 详情 详情
(XII) 45046 methyl isocyanate; (methylimino)(oxo)methane C2H3NO 详情 详情

合成路线4

该中间体在本合成路线中的序号:

The bromination of tetraline (XIX) with Br2 in hexane gives trans-1,2-dibromotetraline (XX), which by treatment with H2O and NaHCO3 yields trans-2-bromotetralin-1-ol (XXI) [also obtained by reaction of 1,2-dihydronaphthalene (XXII) with 1,3-dibromo-5,5-dimethylhydantoin (DBDH) and perchloric acid]. The reaction of (XXI) with methylamine affords the intermediate epoxide (XXIII), which without isolation with more methylamine gives trans 1-(methylamino) tetralin-2-ol as a racemic mixture rac-(XXIV). The optical resolution of this mixture with (+)-L-tartaric acid yields the desired enantiomer (R,R)(XXIV), which is condensed with 2-bromoacetaldehyde dimethyl acetal (XXV) by means of K2CO3 in acetonitrile furnishing the chiral tertiary amine (XXVI). The cyclization of (XXVI) with BuLi and TsCl provides the intermediate aziridinium salt (XXVII), which without isolation, is condensed with 4-chloro-3-methoxyphenyl-magnesium bromide (X) in THF to give the chiral tertiary amine (XXVIII). The cyclization of (XXVIII) by means of methanesulfonic acid yields the chiral tetracyclic compound (XXIX), which is hydrogenated by means of BH3/t-Bu-NH2 to afford (6aS,13bR)(VIII). Finally, this compound is demethylated with 48% HBr in acetic acid. The chiral secondary amine (XXVI) can also be obtained as follows: The enantioselective epoxidation of 1,2-dihydronaphthalene (XXII) by means of a chiral manganese catalyst and sodium hypochlorite gives the chiral epoxide (1S,2R)(XXIII), which is cleaved with 2-(methylamino)acetaldehyde dimethylacetal (XXX) at 95 C in a pressure vessel to yield the desired chiral secondary amine (XXVI).

1 Berger, J.G.; Clader, J.W.; Chang, W.K.; Gold, E.H. (Schering Corp.); Fused benzazepines. EP 0230270; EP 0254737; JP 1988502348; WO 8704430 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(VIII) 31779 (3aS,9bR)-12-chloro-11-methoxy-3-methyl-2,3,3a,4,5,9b-hexahydro-1H-naphtho[1,2-a][3]benzazepine; (3aS,9bR)-12-chloro-3-methyl-2,3,3a,4,5,9b-hexahydro-1H-naphtho[1,2-a][3]benzazepin-11-yl methyl ether C20H22ClNO 详情 详情
(X) 36324 methyl 2-chloro-3-[4-[4-(2-chloro-3-methoxy-3-oxopropyl)benzyl]phenyl]propanoate C21H22Cl2O4 详情 详情
(XIX) 36632 1,2,3,4-tetrahydronaphthalene 119-64-2 C10H12 详情 详情
(XX) 36633 (1S,2S)-1,2-dibromo-1,2,3,4-tetrahydronaphthalene C10H10Br2 详情 详情
(XXI) 36634 (1S,2S)-2-bromo-1,2,3,4-tetrahydro-1-naphthalenol C10H11BrO 详情 详情
(XXII) 36635 1,2-dihydronaphthalene 447-53-0 C10H10 详情 详情
(XXIII) 36636 (1aR,7bS)-1a,2,3,7b-tetrahydronaphtho[1,2-b]oxirene C10H10O 详情 详情
(XXIV) 36637 (1R,2R)-1-(methylamino)-1,2,3,4-tetrahydro-2-naphthalenol C11H15NO 详情 详情
(XXV) 13183 2-Bromo-1,1-dimethoxyethane; 2-Bromo-1-methoxyethyl methyl ether; Bromoacetaldehyde dimethyl acetal 7252-83-7 C4H9BrO2 详情 详情
(XXVI) 36638 (1R,2R)-1-[(2,2-dimethoxyethyl)(methyl)amino]-1,2,3,4-tetrahydro-2-naphthalenol C15H23NO3 详情 详情
(XXVII) 36639   n/a AB 详情 详情
(XXVIII) 36640 N-[(1S,2S)-1-(4-chloro-3-methoxyphenyl)-1,2,3,4-tetrahydro-2-naphthalenyl]-N-(2,2-dimethoxyethyl)-N-methylamine; (1S,2S)-1-(4-chloro-3-methoxyphenyl)-N-(2,2-dimethoxyethyl)-N-methyl-1,2,3,4-tetrahydro-2-naphthalenamine C22H28ClNO3 详情 详情
(XXIX) 36641 (3aS,9bR)-12-chloro-3-methyl-3a,4,5,9b-tetrahydro-3H-naphtho[1,2-a][3]benzazepin-11-yl methyl ether; (3aS,9bR)-12-chloro-11-methoxy-3-methyl-3a,4,5,9b-tetrahydro-3H-naphtho[1,2-a][3]benzazepine C20H20ClNO 详情 详情
(XXX) 36650 2,2-dimethoxy-N-methyl-1-ethanamine;1,1-Dimethoxy-2-(methylamino)-ethane;Methylaminoacetaldehyde dimethyl acetal;N-(2,2-dimethoxyethyl)-N-methylamine 122-07-6 C5H13NO2 详情 详情

合成路线5

该中间体在本合成路线中的序号:(II)

The condensation of bromoacetaldehyde dimethyl acetal (I) with methylamine (II) by means of KOH in refluxing ethylene glycol gives bis(2,2-dimethoxyethyl)methylamine (III), which is cyclized with acetonedicarboxylic acid (IV) and more methylamine (II), yielding 3,9-dimethyl-3,9-diazabicyclo[3.3.1]nonan-7-one (V). The reaction of (V) with hydroxylamine affords the corresponding oxime (VI), which is reduced with H2 over RaNi in ethanol giving endo-3,9-dimethyl-3,9-diazabicyclo[3.3.1]nonan-7-amine (VII). Finally, this compound is condensed with 1H-indazole-3-carbonyl chloride (VIII) by means of dimethylaminopyridine (DMAP) in pyridine.

1 Castaner, J.; Rabasseda, X.; Mealy, N.; N-3389. Drugs Fut 1995, 20, 8, 780.
2 Kikuchi, H.; Satoh, H.; Yahata, N.; Hagihara, K.; Hayakawa, T.; Mino, S.; Yanai, M. (Nisshin Flour Milling Co., Ltd.); Azabicyclo derivs. and their use as antiemetics. EP 0469449; JP 1993310749; US 5187166 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13183 2-Bromo-1,1-dimethoxyethane; 2-Bromo-1-methoxyethyl methyl ether; Bromoacetaldehyde dimethyl acetal 7252-83-7 C4H9BrO2 详情 详情
(II) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(III) 15529 N-(2,2-dimethoxyethyl)-2,2-dimethoxy-N-methyl-1-ethanamine; N,N-bis(2,2-dimethoxyethyl)-N-methylamine; 2,2'-Methyliminobis-(acetaldehyde dimethyl acetal) 70887-96-6 C9H21NO4 详情 详情
(IV) 15530 1,3-Acetonedicarboxylic Acid; 3-Oxopentanedioic acid;3-oxoglutaric acid 542-05-2 C5H6O5 详情 详情
(V) 15531 (1R,5S)-3,9-dimethyl-3,9-diazabicyclo[3.3.1]nonan-7-one C9H16N2O 详情 详情
(VI) 15532 (1R,5S)-3,9-dimethyl-3,9-diazabicyclo[3.3.1]nonan-7-one oxime C9H17N3O 详情 详情
(VII) 15533 (1R,5S)-3,9-dimethyl-3,9-diazabicyclo[3.3.1]non-7-ylamine; (1R,5S)-3,9-dimethyl-3,9-diazabicyclo[3.3.1]nonan-7-amine C9H19N3 详情 详情
(VIII) 15534 1H-indazole-3-carbonyl chloride C8H5ClN2O 详情 详情

合成路线6

该中间体在本合成路线中的序号:(VI)

Synthesis of the aminopyrazole intermediate (XIII): The reaction of butanal (I) with methylhydrazine (II) in dichloromethane in the presence of MgSO4 gives the corresponding hydrazide (III), which is alkylated with ethyl bromoacetate (IV) by means of the polymer-supported base 2-(tert-butylimino)-2-(diethylamino)-1,3-dimethylperhydro-1,3,2-diazaphosphorine (PS-BEMP) (V) and polymer-supported methylamine (VI) to yield the hydrazino ester (VII). Treatment of compound (VII) with an ion exchange tetramethylammonium cyanide resin (VIII) in refluxing ethanol containing a catalytic amount of HOAc affords the adduct (IX), which is dehydrogenated with Pd/C/cyclopentene or MnO2 and treated with a polymer-supported ethyl isocyanate resin (X) in order to eliminate the unreacted product, providing the hydrazone (XI). Cyclization of (XI) by means of PS-BEMP (V) in ethanol gives 4-amino-1-methyl-3-propyl-1H-pyrazole-5-carboxylic acid ethyl ester (XII), which is finally treated with ammonia in methanol to afford the desired pyrazolecarboxamide intermediate (XIII).

1 Baxendale, I.R.; Ley, S.V.; Polymer-supported reagents for multi-step organic synthesis: Application to the synthesis of sildenafil. Bioorg Med Chem Lett 2000, 10, 17, 1983.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 23694 butyraldehyde 123-72-8 C4H8O 详情 详情
(II) 12091 1-Methylhydrazine; Monomethyl hydrazine 60-34-4 CH6N2 详情 详情
(III) 44339 butanal N-methylhydrazone C5H12N2 详情 详情
(IV) 16640 Ethyl 2-bromoacetate; Ethyl bromoacetate 105-36-2 C4H7BrO2 详情 详情
(V) 44344 N-(tert-butyl)-N-[2-(diethylamino)-1,3-dimethyl-1,3,2lambda(5)-diazaphosphinan-2-ylidene]amine; 2-(tert-butylimino)-N,N-diethyl-1,3-dimethyl-1,3,2lambda(5)-diazaphosphinan-2-amine C13H31N4P 详情 详情
(VI) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(VII) 44340 ethyl 2-[2-[(E)butylidene]-1-methylhydrazino]acetate C9H18N2O2 详情 详情
(VIII) 44345 N,N,N-trimethylmethanaminium cyanide C5H12N2 详情 详情
(IX) 44341 ethyl 2-[2-(1-cyanobutyl)-1-methylhydrazino]acetate C10H19N3O2 详情 详情
(X) 11019 (Methylimino)(oxo)methane; methyl isocyanate C2H3NO 详情 详情
(XI) 44342 ethyl 2-[2-[(Z)-1-cyanobutylidene]-1-methylhydrazino]acetate C10H17N3O2 详情 详情
(XII) 44343 ethyl 4-amino-1-methyl-3-propyl-1H-pyrazole-5-carboxylate C10H17N3O2 详情 详情
(XIII) 15627 4-amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide; 4-amino-1-methyl-3-propyl-5-pyrazolecarboxamide 139756-02-8 C8H14N4O 详情 详情

合成路线7

该中间体在本合成路线中的序号:

The reductocondensation of naltrexone (I) with N-methylbenzylamine (II) by means of sodium cyanoborohydride in THF gives the N-benzyl-N-methylaminomorphinan derivative (III), which is debenzylated by hydrogenation with H2 over Pd/C in methanol yielding the methylaminomorphinan (IV). Finally, this compound is acylated with 3(E)-(3-furyl)acryloyl chloride and NaOH, Na2CO3 or triethylamine in methanol, THF or chloroform. Alternatively, methylaminomorphinan (IV) can also be obtained by direct reductocondensation of naltrexone (I) with methylamine by means of H2 over PtO2 in methanol.

1 Leeson, P.A.; Sorbera, L.A.; Castañer, J.; Nalfurafine Hydrochloride. Drugs Fut 2003, 28, 3, 237.
2 Nagase, H.; et al.; Discovery of a structurally novel opioid kappa-agonist derived from 4,5-epoxymorphinan. Chem Pharm Bull 1998, 46, 2, 366.
3 Nagase, H.; Hayakawa, J.; Kawamura, H.; Kawai, K.; Endoh, T. (Toray Industries, Inc.); Morphinan derivative and medicinal use. AU 686203; AU 7237394; EP 0663401 .
4 Nagase, H.; Kawai, K.; Endo, T.; Ueno, S.; Negishi, Y. (Toray Industries, Inc.); Antitussive. EP 0657163; JP 1995503397; US 5739145; WO 9501178 .
5 Nagase, H.; Kawai, K.; Kawamura, K.; Hayakawa, J.; Endo, T. (Toray Industries, Inc.); Morphinan deriv. and medicinal use. EP 0577847; EP 0846694; JP 1994509616; US 6277859; US 6323212; WO 9315081 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(I) 25079 (1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0(1,13).0(5,17).0(7,18)]octadeca-7(18),8,10-trien-14-one; Naltrexone 16590-41-3 C20H23NO4 详情 详情
(II) 11969 N-Methyl(phenyl)methanamine; N-Benzyl-N-methylamine; N-Methylbenzylamine 103-67-3 C8H11N 详情 详情
(III) 25080 (1S,5R,13R,14R,17S)-14-[benzyl(methyl)amino]-4-(cyclopropylmethyl)-12-oxa-4-azapentacyclo[9.6.1.0(1,13).0(5,17).0(7,18)]octadeca-7(18),8,10-triene-10,17-diol C28H34N2O3 详情 详情
(IV) 25081 (1S,5R,13R,14R,17S)-4-(cyclopropylmethyl)-14-(methylamino)-12-oxa-4-azapentacyclo[9.6.1.0(1,13).0(5,17).0(7,18)]octadeca-7(18),8,10-triene-10,17-diol C21H28N2O3 详情 详情
(V) 25082 (E)-3-(3-furyl)-2-propenoyl chloride C7H5ClO2 详情 详情

合成路线8

该中间体在本合成路线中的序号:(V)

The reductocondensation of ethanolamine (I) with 3-methylbenzaldehyde (II) by means of NaBH4 gives N-(3-methylbenzyl)ethanolamine (III), which is treated with SOCl2 to yield the 2-chloroethyl derivative (IV). The reaction of (IV) with methylamine (V) affords N-methyl-N'-(3-methylbenzyl)ethane-1,2-diamine (VI), which is condensed with the pyrazole-carboxamide derivative (VII) to provide the unstable compound (VIII)?? (IX). The reduction of (IX) with NaBH4 gives the racemic amide (X), which is submitted to optical resolution by preferential crystallization to yield the (R)-isomer (XI) (1,2). The hydrogenation of (XI) with H2 over Pd/C in ethanol affords the debenzylated compound (XII), which is alkylated by reductocondensation with acetaldehyde (XIII) and NaBH4 in methanol to provide the chiral N-(1-ethyl-4'-methylperhydro-1,4-diazepin-6-(R)-yl)-1H-pyrazole-3-carboxamide (XIV). Finally, this compound is treated with refluxing aqueous HCl to give the corresponding 6(R)-amino derivative (XV).

2 Hirokawa, Y.; et al.; Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist. Chem Pharm Bull 2002, 50, 7, 941.
1 Harada, H.; et al.; Synthesis and resolution of (±)-N-[1-methyl-4-(3-methylbenzyl)hexahydro-1H-1,4-diazepin-6-yl]-1H-indazole-3-carboxamide by preferential crystallization. Tetrahedron Asymmetry 1997, 8, 14, 2367.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10259 Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol 141-43-5 C2H7NO 详情 详情
(II) 41077 3-methylbenzaldehyde 620-23-5 C8H8O 详情 详情
(III) 58175 2-[(3-methylbenzyl)amino]-1-ethanol C10H15NO 详情 详情
(IV) 58176 2-chloro-N-(3-methylbenzyl)-1-ethanamine; N-(2-chloroethyl)-N-(3-methylbenzyl)amine C10H14ClN 详情 详情
(V) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(VI) 54009 N~1~-methyl-N~2~-(3-methylbenzyl)-1,2-ethanediamine; N-methyl-N-{2-[(3-methylbenzyl)amino]ethyl}amine n/a C11H18N2 详情 详情
(VII) 58177 ethyl 3-{[(1-formylvinyl)amino]carbonyl}-1H-indazole-1-carboxylate C14H13N3O4 详情 详情
(VIII) 58178 ethyl 3-({[1-formyl-2-(methyl{2-[(3-methylbenzyl)amino]ethyl}amino)ethyl]amino}carbonyl)-1H-indazole-1-carboxylate C25H31N5O4 详情 详情
(IX) 58179 6-({[1-(ethoxycarbonyl)-1H-indazol-3-yl]carbonyl}amino)-4-methyl-1-(3-methylbenzyl)-3,4,5,6-tetrahydro-2H-1,4-diazepin-1-ium C25H30N5O3 详情 详情
(X) 58180 N-[1-methyl-4-(3-methylbenzyl)-1,4-diazepan-6-yl]-1H-indazole-3-carboxamide C22H27N5O 详情 详情
(XI) 58181 N-[(6S)-1-methyl-4-(3-methylbenzyl)-1,4-diazepan-6-yl]-1H-indazole-3-carboxamide C22H27N5O 详情 详情
(XII) 58182 N-[(6S)-1-methyl-1,4-diazepan-6-yl]-1H-indazole-3-carboxamide C14H19N5O 详情 详情
(XIII) 11974 Acetaldehyde 75-07-0 C2H4O 详情 详情
(XIV) 58183 N-[(6S)-1-ethyl-4-methyl-1,4-diazepan-6-yl]-1H-indazole-3-carboxamide C16H23N5O 详情 详情
(XV) 17802 (6S)-1-ethyl-4-methyl-1,4-diazepan-6-ylamine; (6S)-1-ethyl-4-methyl-1,4-diazepan-6-amine C8H19N3 详情 详情

合成路线9

该中间体在本合成路线中的序号:(IV)

Nolomirole is synthesized by acylation of (rac)-6-(methylamino)-5,6,7,8-tetrahydronaphthalene-1,2-diol, CHF-1024 (I) with isobutyryl chloride (II) in THF. Reductocondensation of 5,6-dimethoxy-2-tetralone (III) with methylamine (IV) by means of LiBH4 or NaBH4 gives N-(5,6-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl)-N-methylamine (V), which is treated with 48% HBr at 110 C.

1 Castaner, J.; Mealy, N.E.; Bayes, M.; Leeson, P.A.; Nolomirole Hydrochloride. Drugs Fut 2001, 26, 11, 1046.
2 Chiesi, P.; Villani, V. (Chiesi Farmaceutici SpA); 1,2,3,4-Tetrahydronaphthaline derivs., process for their preparation and pharmaceutical compsns. containing them. DE 3320936; GB 2123410 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 49435 6-(methylamino)-5,6,7,8-tetrahydro-1,2-naphthalenediol C11H15NO2 详情 详情
(II) 14932 isobutyryl chloride; 2-methylpropanoyl chloride 79-30-1 C4H7ClO 详情 详情
(III) 37386 5,6-dimethoxy-3,4-dihydro-2(1H)-naphthalenone C12H14O3 详情 详情
(IV) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(V) 37381 N-(5,6-dimethoxy-1,2,3,4-tetrahydro-2-naphthalenyl)-N-methylamine; 5,6-dimethoxy-N-methyl-1,2,3,4-tetrahydro-2-naphthalenamine C13H19NO2 详情 详情

合成路线10

该中间体在本合成路线中的序号:(IV)

The condensation of 2,3-dimethoxybenzaldehyde (VI) with pyruvic acid (VII) by means of KOH in ethanol/water gives 4-(2,3-dimethoxyphenyl)-2-oxo-3-butenoic acid (VIII), which is reductocondensed with methylamine (IV) by means of H2 over Pd/C in ethanol/ acetic acid to yield 4-(2,3-dimethoxyphenyl)-2-methylamino)butyric acid (IX). Reaction of acid (IX) with benzyl chloroformate (X) and NaOH in water affords the carbamate (XI), which is treated with refluxing SOCl2 to provide 4-[2-(2,3-dimethoxyphenyl)ethyl]-3-methyloxazolidine-2,5-dione (XII). Reaction of oxazolidinone (XII) with AlCl3 in dichloromethane provides 5,6-dimethoxy-2-(methylamino)-1,2,3,4-tetrahydronaphthalen-1-one (XIII), which is reduced with H2 over Pd/C in ethanol containing some methanolic HCl in an autoclave at 80 C to yield N-(5,6-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl)-N-methylamine (V). Finally, this compound is demethylated by treatment with AlCl3 in hot toluene. Alternatively, 5,6-dimethoxy-2-(methylamino)-1,2,3,4-tetrahydronaphthalen-1-one (XIII) can first be demethylated with 48% HBr to give 5,6-dihydroxy-2-(methylamino)-1,2,3,4-tetrahydronaphthalen-1-one (XIV), which is then reduced by means of H2 over Pd/C in an autoclave at 80 C.

1 Castaner, J.; Mealy, N.E.; Bayes, M.; Leeson, P.A.; Nolomirole Hydrochloride. Drugs Fut 2001, 26, 11, 1046.
2 Servadio, V.; Ventura, P.; Amari, G.; Chiesi, P.; Del Canale, M.; De Fanti, R. (Chiesi Farmaceutici SpA); A process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivs.. WO 9529147 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 49435 6-(methylamino)-5,6,7,8-tetrahydro-1,2-naphthalenediol C11H15NO2 详情 详情
(IV) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(V) 37381 N-(5,6-dimethoxy-1,2,3,4-tetrahydro-2-naphthalenyl)-N-methylamine; 5,6-dimethoxy-N-methyl-1,2,3,4-tetrahydro-2-naphthalenamine C13H19NO2 详情 详情
(VI) 17615 2,3-Dimethoxybenzaldehyde 86-51-1 C9H10O3 详情 详情
(VII) 24066 2-oxopropionic acid 127-17-3 C3H4O3 详情 详情
(VIII) 37376 (E)-4-(2,3-dimethoxyphenyl)-2-oxo-3-butenoic acid C12H12O5 详情 详情
(IX) 37377 4-(2,3-dimethoxyphenyl)-2-(methylamino)butyric acid C13H19NO4 详情 详情
(X) 10101 Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene 501-53-1 C8H7ClO2 详情 详情
(XI) 37378 2-[[(benzyloxy)carbonyl](methyl)amino]-4-(2,3-dimethoxyphenyl)butyric acid C21H25NO6 详情 详情
(XII) 37379 4-(2,3-dimethoxyphenethyl)-3-methyl-1,3-oxazolidine-2,5-dione C14H17NO5 详情 详情
(XIII) 37380 5,6-dimethoxy-2-(methylamino)-3,4-dihydro-1(2H)-naphthalenone C13H17NO3 详情 详情
(XIV) 37387 5,6-dihydroxy-2-(methylamino)-3,4-dihydro-1(2H)-naphthalenone C11H13NO3 详情 详情

合成路线11

该中间体在本合成路线中的序号:

Ring opening of cyclohexene oxide (I) with aqueous methylamine gave trans 2-(methylamino)cyclohexanol (II), which was further cyclized to the aziridine (III) upon treatment with chlorosulfonic acid and then with NaOH. Subsequent condensation of (III) with pyrrolidine (IV) yielded the racemic trans diamine (V). Resolution was achieved by fractional crystallization of the 2,3-di-p-toluoyl-D-tartaric acid salt in MeOH. The required (-)-(R,R) enantiomer was finally coupled with 4-benzothiopheneacetyl chloride (VI) to provide the corresponding amide.

1 MacLeod, B.A.; Walker, M.J.A.; Wall, R.A. (University of British Columbia); Aminocyclohexylamides for antiarrhythmic and anaesthetic uses. EP 0632806; JP 1995505151; US 5506257; WO 9319056 .
2 Bain, A.I. (Nortran Pharmaceuticals Inc.); Mixtures of enantiomers of aminocyclohexylamides to produce simultaneous analgesia with local anaesthesia or antiarrhythmia. WO 9916431 .
3 Halfpenny, P.R.; Schofield, D.; Hughes, J.; Rees, D.C.; Jarvis, T.C.; Hill, R.G.; Horwell, D.C.; Clark, C.R.; Highly selective kappa opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivatives. J Med Chem 1988, 31, 4, 831.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(+)-(V) 11051 (1S,2S)-N-Methyl-2-(1-pyrrolidinyl)cyclohexanamine; N-Methyl-N-[(1S,2S)-2-(1-pyrrolidinyl)cyclohexyl]amine C11H22N2 详情 详情
(-)-(V) 31357 N-methyl-N-[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]amine; (1R,2R)-N-methyl-2-(1-pyrrolidinyl)cyclohexanamine C11H22N2 详情 详情
(I) 17986 7-oxabicyclo[4.1.0]heptane; cyclohexene oxide 286-20-4 C6H10O 详情 详情
(II) 31355 (1R,2R)-2-(methylamino)cyclohexanol C7H15NO 详情 详情
(III) 31356 7-methyl-7-azabicyclo[4.1.0]heptane C7H13N 详情 详情
(IV) 11376 Pyrrolidine 123-75-1 C4H9N 详情 详情
(VI) 11050 2-(1-Benzothiophen-4-yl)acetyl chloride C10H7ClOS 详情 详情

合成路线12

该中间体在本合成路线中的序号:

3,3-Diphenylpropionic acid (I) was treated with SOCl2 to give acid chloride (II) and then converted to amide (III) using liquid ammonia. Dehydration with P2O5 led to diphenylpropionitrile (IV), which was treated with SOCl2 in methanol to afford the iminoester (V). The condensation of (V) wiith 2-oxobutan-1,4-diol (VI) in liquid ammonia furnished imidazole (VII). Further treatment of (VII) with SOCl2 provided chloride (VIII). Finally, reaction of (VIII) with methylamine in the presence of K2CO3 and a catalytic amount of KI afforded the title compound.

1 Schunack, W.; Detert, H.; Pertz, H.H.; Kramer, K.; ter Laak, A.M.; Kühne, RF.; Elz, S.; Histaprofidens: Synthesis, pharmacological in vitro evaluation, and molecular modeling of a new class of highly active and selective histamine H1-receptor agonists. J Med Chem 2000, 43, 6, 1071.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(I) 36717 3,3-diphenylpropionic acid 606-83-7 C15H14O2 详情 详情
(II) 36718 3,3-diphenylpropanoyl chloride C15H13ClO 详情 详情
(III) 36719 3,3-diphenylpropanamide C15H15NO 详情 详情
(IV) 36720 3,3-diphenylpropanenitrile 2286-54-6 C15H13N 详情 详情
(V) 36721 methyl 3,3-diphenylpropanimidoate C16H17NO 详情 详情
(VI) 36722 1,4-dihydroxy-2-butanone C4H8O3 详情 详情
(VII) 36723 2-[2-(3,3-diphenylpropyl)-1H-imidazol-4-yl]-1-ethanol C20H22N2O 详情 详情
(VIII) 36724 4-(2-chloroethyl)-2-(3,3-diphenylpropyl)-1H-imidazole C20H21ClN2 详情 详情

合成路线13

该中间体在本合成路线中的序号:

Condensation of bis(2-chloroethyl)phosphoramidic dichloride (I) with the sodium salt of 3-buten-1-ol (II) gave the O-butenyl phosphoramidate (III), which was subsequently reacted with methylamine to produce the phosphorodiamidate (IV). Ozonization of the double bond of (IV), followed by oxidative workup with H2O2 yielded aldehyde (V). This was finally condensed with 2-mercaptoethanesulfonic acid cyclohexylamine salt (VI) to furnish the title compound.

1 Moon, K.; Kwon, C.; N3-methyl-mafosfamide as a chemically stable, alternative prodrug of mafosfamide. Bioorg Med Chem Lett 1998, 8, 13, 1673.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(I) 31443 (Bis(2-Chloroethyl)amino]phosphoryl dichloride; Bis(2-Chloroethyl)phosphoramidic dichloride C4H8Cl4NOP 详情 详情
(II) 19743 3-buten-1-ol 627-27-0 C4H8O 详情 详情
(III) 31444 [Bis(2-chloroethyl)amino](3-butenyloxy)phosphoryl chloride C8H15Cl3NO2P 详情 详情
(IV) 31445 N,N-Bis(2-chloroethyl)-N'-methyldiamidophosphoric acid 3-butenyl ester C9H19Cl2N2O2P 详情 详情
(V) 31446 N,N-Bis(2-chloroethyl)-N'-methyldiamidophosphoric acid 2-formylethyl ester C8H17Cl2N2O3P 详情 详情
(VI) 31447 2-mercxaptoethane sulfonic acid cyclothexylamine C8H19NO3S2 详情 详情

合成路线14

该中间体在本合成路线中的序号:

Reduction of 3-chloropropiophenone (I) with NaBH4 produced 3-chloro-1-phenyl-1-propanol (II). Subsequent Mitsunobu coupling of (II) with 2-(methylthio)phenol (III) in the presence of DEAD and PPh3 afforded ether (IV). Finally, substitution of the halogen of (IV) for methylamine provided the corresponding secondary amine.

1 Gehlert, D.R.; Robertson, D.W.; Wong, D.T. (Eli Lilly and Company); N-Alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamines. EP 0591581 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(I) 28073 3-chloro-1-phenyl-1-propanone 936-59-4 C9H9ClO 详情 详情
(II) 28074 3-chloro-1-phenyl-1-propanol C9H11ClO 详情 详情
(III) 28075 2-(methylsulfanyl)phenol 1073-29-6 C7H8OS 详情 详情
(IV) 28076 1-(3-chloro-1-phenylpropoxy)-2-(methylsulfanyl)benzene C16H17ClOS 详情 详情

合成路线15

该中间体在本合成路线中的序号:(II)

The reductocondensation of tetrahydropyran-4-one (I) with methylamine (II) by means of H2 over Pd/C in methanol gives 4-(methylamino)tetrahydropyran (III), which is then alkylated with 4-nitrobenzyl bromide (IV) and K2CO3 in DMF to yield the tertiary amine (V). Finally, the nitro group of (V) is educed with SnCl2 and conc. aq. HCl to afford N-(4-aminobenzyl)-N-methyl-N-(tetrahydropyran-4-yl)amine, the target intermediate (VI).

1 Hashimoto, H.; et al.; Process development of 4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline dihydrochloride: A key intermediate for TAK-779, a small-molecule nonpeptide CCR5 antagonist. Org Process Res Dev 2002, 6, 1, 70.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 31563 tetrahydro-4H-pyran-4-one 29943-42-8 C5H8O2 详情 详情
(II) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(III) 55002 N-methyl-N-tetrahydro-2H-pyran-4-ylamine; N-methyltetrahydro-2H-pyran-4-amine C6H13NO 详情 详情
(IV) 16866 1-(Bromomethyl)-4-nitrobenzene; para-Nitrobenzyl bromide 100-11-8 C7H6BrNO2 详情 详情
(V) 31565 N-methyl-N-(4-nitrobenzyl)tetrahydro-2H-pyran-4-amine; N-methyl-N-(4-nitrobenzyl)-N-tetrahydro-2H-pyran-4-ylamine C13H18N2O3 详情 详情
(VI) 31566 N-(4-aminobenzyl)-N-methyltetrahydro-2H-pyran-4-amine; N-(4-aminobenzyl)-N-methyl-N-tetrahydro-2H-pyran-4-ylamine C13H20N2O 详情 详情

合成路线16

该中间体在本合成路线中的序号:

Curtius rearrangement of arachidonic acid (I) in the presence of diphenyl phosphoryl azide in hot benzene gave isocyanate (II), which was coupled with methylamine to yield the title urea.

1 Aung, M.M.; Abood, M.E.; Martin, B.R.; Razdan, R.K.; Ng, E.W.; Unique analogues of anandamide: Arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas. J Med Chem 1999, 42, 1975.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(I) 21406 (5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoic acid 7771-44-0 C20H32O2 详情 详情
(II) 26237 (4Z,7Z,10Z,13Z)-1-isocyanato-4,7,10,13-nonadecatetraene; (4Z,7Z,10Z,13Z)-4,7,10,13-nonadecatetraenyl isocyanate C20H31NO 详情 详情

合成路线17

该中间体在本合成路线中的序号:

The intermediate naphthylmethyl amine (IV) was prepared from 1-naphthaldehyde (I) by two related procedures. Reduction of (II) with NaBH4 gave alcohol (II), which was converted to the corresponding chloride with SOCl2 and then condensed with methylamine. Alternatively, condensation of aldehyde (I) with methylamine using TiCl4 as the dehydrating reagent produced aldimine (III), which was then reduced to amine (IV) by means of NaBH4.

1 Zhou, Y.; Zhang, W.; Li, K.; Jiang, Y.; Li, Y.; Wang, X.; The synthesis and antifungal activity of the substituted naphthalenemethanamines. Chin Journal of Medicinal Chemistry 1999, 9, 7, 7.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(I) 12314 1-Naphthaldehyde 66-77-3 C11H8O 详情 详情
(II) 35129 1-naphthylmethanol 4780-79-4 C11H10O 详情 详情
(III) 35130 N-[(Z)-1-naphthylmethylidene]methanamine; N-methyl-N-[(Z)-1-naphthylmethylidene]amine C12H11N 详情 详情
(IV) 10108 N-Methyl(1-naphthyl)methanamine; N-Methyl-N-(1-naphthylmethyl)amine; 1-Methyl-1-naphthalenemethylamine 65473-13-4 C12H13N 详情 详情

合成路线18

该中间体在本合成路线中的序号:

Aminotetralin (VIII) was obtained by reductive amination of the 2-tetralone (XIV) in the presence of NaBH3CN.

1 Chiesi, P.; Villani, V. (Chiesi Farmaceutici SpA); 1,2,3,4-Tetrahydronaphthaline derivs., process for their preparation and pharmaceutical compsns. containing them. DE 3320936; GB 2123410 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(VIII) 37381 N-(5,6-dimethoxy-1,2,3,4-tetrahydro-2-naphthalenyl)-N-methylamine; 5,6-dimethoxy-N-methyl-1,2,3,4-tetrahydro-2-naphthalenamine C13H19NO2 详情 详情
(XIV) 37386 5,6-dimethoxy-3,4-dihydro-2(1H)-naphthalenone C12H14O3 详情 详情

合成路线19

该中间体在本合成路线中的序号:

The condensation of N-Boc-N-methyl-D-phenylalanine (VIII) with methylamine by means of EDC and HOBt gave the corresponding amide (IX). After acid deprotection of the Boc group of (IX), the resulting amino compound (X) was coupled with N-Boc-N-methyl-D-naphthylalanine (XI) using EDC and HOAt to provide dipeptide (XII). The Boc protecting group of (XII) was further cleaved with trifluoroacetic acid to give (XIII).

1 Hansen, T.K.; Peschke, B.; Lau, J.; Lundt, B.F.; Ankersen, M.; Watson, B.; Madsen, K. (Novo Nordisk A/S); Cpds. with growth hormone releasing properties. JP 1999209336; JP 1999501054; JP 2000143613; US 6127391; WO 9723508 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(VIII) 22185 (2R)-2-[(tert-butoxycarbonyl)(methyl)amino]-3-phenylpropionic acid 37553-65-4 C15H21NO4 详情 详情
(IX) 27231 tert-butyl (1R)-1-benzyl-2-(methylamino)-2-oxoethyl(methyl)carbamate C16H24N2O3 详情 详情
(X) 27232 (2R)-N-methyl-2-(methylamino)-3-phenylpropanamide C11H16N2O 详情 详情
(XI) 22189 (2R)-2-[(tert-butoxycarbonyl)(methyl)amino]-3-(2-naphthyl)propionic acid 147577-61-5 C19H23NO4 详情 详情
(XII) 27233 tert-butyl (1R)-2-[[(1R)-1-benzyl-2-(methylamino)-2-oxoethyl](methyl)amino]-1-(2-naphthylmethyl)-2-oxoethyl(methyl)carbamate C30H37N3O4 详情 详情
(XIII) 27234 (2R)-N-[(1R)-1-benzyl-2-(methylamino)-2-oxoethyl]-N-methyl-2-(methylamino)-3-(2-naphthyl)propanamide C25H29N3O2 详情 详情

合成路线20

该中间体在本合成路线中的序号:

2-Pyrrolidinone (I) was protected as the N-Boc derivative (II) and then alkylated with 3-bromo-2-methylpropene (III) in the presence of LDA to yield (IV). Further alkylation of (IV) with tert-butyl bromoacetate gave the dialkylated pyrrolidinone (V). Catalytic hydrogenation of the 2-methylpropenyl substituent of (V) produced the racemic isobutyl analogue (VI), which was resolved by means of chiral HPLC. The desired (S)-enantiomer (VII) was deprotected by treatment with magnesium ethoxide, affording pyrrolidinone (VIII). N-Alkylation of the pyrrolidinone (VIII) with triflate (IX) furnished adduct (X), which was hydrolyzed to carboxylic acid (XI) with methanolic NaOH. After activation of (XI) with carbonyl diimidazole, coupling with methylamine gave rise to amide (XII). Cleavage of the tert-butyl ester group of (XII) employing trifluoroacetic acid produced carboxylic acid (XIII). This was finally coupled with hydroxylamine using EDC and HOBt.

1 Jacobsen, E.J. (Pharmacia & Upjohn AB); Hydroxamic acid derivs. for use with the treatment of diseases related to connective tissue degradation. EP 0898562; JP 2000506163; US 5712300; WO 9732846 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
17430 2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate 5292-43-3 C6H11BrO2 详情 详情
(I) 27397 2-Pyrrolidinone 616-45-5 C4H7NO 详情 详情
(II) 40014 tert-butyl 2-oxo-1-pyrrolidinecarboxylate C9H15NO3 详情 详情
(III) 40015 3-bromo-2-methyl-1-propene 1458-98-6 C4H7Br 详情 详情
(IV) 40016 tert-butyl 3-(2-methyl-2-propenyl)-2-oxo-1-pyrrolidinecarboxylate C13H21NO3 详情 详情
(V) 40017 tert-butyl 3-[2-(tert-butoxy)-2-oxoethyl]-3-(2-methyl-2-propenyl)-2-oxo-1-pyrrolidinecarboxylate C19H31NO5 详情 详情
(VI) 40018 tert-butyl 3-[2-(tert-butoxy)-2-oxoethyl]-3-isobutyl-2-oxo-1-pyrrolidinecarboxylate C19H33NO5 详情 详情
(VII) 40019 tert-butyl (3S)-3-[2-(tert-butoxy)-2-oxoethyl]-3-isobutyl-2-oxo-1-pyrrolidinecarboxylate C19H33NO5 详情 详情
(VIII) 40020 tert-butyl 2-[(3S)-3-isobutyl-2-oxopyrrolidinyl]acetate C14H25NO3 详情 详情
(IX) 40025 methyl (2R)-2-cyclohexyl-2-[[(trifluoromethyl)sulfonyl]oxy]ethanoate C10H15F3O5S 详情 详情
(X) 40021 methyl (2S)-2-[(3S)-3-[2-(tert-butoxy)-2-oxoethyl]-3-isobutyl-2-oxopyrrolidinyl]-2-cyclohexylethanoate C23H39NO5 详情 详情
(XI) 40022 (2S)-2-[(3S)-3-[2-(tert-butoxy)-2-oxoethyl]-3-isobutyl-2-oxopyrrolidinyl]-2-cyclohexylethanoic acid C22H37NO5 详情 详情
(XII) 40023 tert-butyl 2-[(3S)-1-[(1S)-1-cyclohexyl-2-(methylamino)-2-oxoethyl]-3-isobutyl-2-oxopyrrolidinyl]acetate C23H40N2O4 详情 详情
(XIII) 40024 2-[(3S)-1-[(1S)-1-cyclohexyl-2-(methylamino)-2-oxoethyl]-3-isobutyl-2-oxopyrrolidinyl]acetic acid C19H32N2O4 详情 详情

合成路线21

该中间体在本合成路线中的序号:

The reduction of omega-chloropropiophenone (I) with NaBH4 in ethanol gives 3-chloro-1-phenyl-1-propanol (II), which is treated with butyric anhydride and pyridine in dichloromethane yielding the corresponding racemic ester (III). The optical resolution of (III) with immobilized lipase B from Candida antarctica (CALB) affords a mixture of unreacted (S)-ester and (R)-alcohol (IV) that are separated by column chromatography. The condensation of alcohol (IV) with 2-methoxyphenol (V) by means of PPh3 and diethyl azodicarboxylate (DEAD) in THF gives the corresponding ether (VI), which is finally treated with methylamine in refluxing ethanol.

1 Anthonsen, T.; Ho, B.H.; Liu, H.L.; Chemoenzymatic synthesis of the non-tricyclic antidepressants fluoxetine, tomoxetine and nisoxetine. J Chem Soc - Perkins Trans I 2000, 11, 11, 1767.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(I) 28073 3-chloro-1-phenyl-1-propanone 936-59-4 C9H9ClO 详情 详情
(II) 28074 3-chloro-1-phenyl-1-propanol C9H11ClO 详情 详情
(III) 37781 3-chloro-1-phenylpropyl butyrate C13H17ClO2 详情 详情
(IV) 37782 (1R)-3-chloro-1-phenyl-1-propanol C9H11ClO 详情 详情
(V) 13182 Guaiacol; 2-Methoxyphenol 90-05-1 C7H8O2 详情 详情
(VI) 37783 1-[[(1R)-3-chloro-1-phenylpropyl]oxy]-2-methoxybenzene; (1R)-3-chloro-1-phenylpropyl 2-methoxyphenyl ether C16H17ClO2 详情 详情

合成路线22

该中间体在本合成路线中的序号:

Alkylation of 4,5,6,7-tetrahydro-1,2-benzisoxazol-3-ol (I) with ethyl bromide in the presence of K2CO3 afforded the ethoxy derivative (II). Subsequent oxidation of (II) with sodium dichromate and H2SO4 provided the desired ketone (III) along with minor amounts of the isomeric 7-oxo compound (IV) that were separated by column chromatography. Conversion of (III) to the corresponding oxime (V), followed by reduction with aluminum amalgam yielded amine (VI). Resolution was achieved via formation of the diastereomeric amides with (R)-alpha-methoxyphenylacetyl chloride (VII) and isolation of the desired isomer (VIII) by preparative HPLC. Cleavage of amide and ether groups of (VIII) by means of HBr furnished (R)-4-amino-3-hydroxy-4,5,6,7-tetrahydro-1,2-benzisoxazole (IX). Protection as the corresponding tert-butyl carbamate, followed by N-methylation with CH3I and NaH provided intermediate (X). An alternative procedure for the preparation of intermediate (X) consisted in the reductive amination of ketone (III) with methylamine and NaBH3CN, followed by condensation of the resulting amine (XI) with the chiral acid chloride (VII) and chromatographic isolation of the desired diastereoisomer (XII). The alpha-methoxyphenylacetyl group of (XII) was then removed by an alternative method consisting in the treatment with lithium triethylborohydride to give the chiral amine (XIII). Cleavage of the ethyl ether group of (XIII) was effected by means of HBr in AcOH, and the resulting compound (XIV) was condensed with di-tert-butyl dicarbonate to produce carbamate (X). Subsequent reaction of (X) with pivaloyloxymethyl iodide (XV) in the presence of potassium tert-butoxide yielded the target O-alkylated compound (XVI) along with some N-alkylated regioisomer. The Boc protecting group of (XVI) was finally removed by treatment with trifluoroacetic acid.

1 Frolund, B.; Falch, E.; Perregaard, J.; et al.; Selective inhibitors of glial GABA uptake: Synthesis, absolute stereochemistry, and pharmacology of the enantiomers of 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole (exo-THPO) and analogues. J Med Chem 1999, 42, 26, 5402.
2 Falch, E.; Moltzen, L.S.; Schousboe, A.; Frolund, B.; Perregaard, J.K.; Krogsgaard-Larsen, P. (H. Lundbeck A/S); 4-Aminotetrahydrobenzisoxazole or -isothiazole cpds.. WO 9626929 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(I) 37236 4,5,6,7-tetrahydro-1,2-benzisoxazol-3-ol C7H9NO2 详情 详情
(II) 37237 ethyl 4,5,6,7-tetrahydro-1,2-benzisoxazol-3-yl ether; 3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazole C9H13NO2 详情 详情
(III) 37238 3-ethoxy-6,7-dihydro-1,2-benzisoxazol-4(5H)-one C9H11NO3 详情 详情
(IV) 37239 3-ethoxy-5,6-dihydro-1,2-benzisoxazol-7(4H)-one C9H11NO3 详情 详情
(V) 37240 3-ethoxy-6,7-dihydro-1,2-benzisoxazol-4(5H)-one oxime C9H12N2O3 详情 详情
(VI) 37241 3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-amine; 3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-ylamine C9H14N2O2 详情 详情
(VII) 16302 (2R)-2-methoxy-2-phenylethanoyl chloride C9H9ClO2 详情 详情
(VIII) 37242 (2R)-N-[(4R)-3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-yl]-2-methoxy-2-phenylethanamide C18H22N2O4 详情 详情
(IX) 37243 (4R)-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazol-3-ol C7H10N2O2 详情 详情
(X) 34244 methyl 2-[(1R,2R,3R)-2-[(benzyloxy)methyl]-5-[(Z)-2-methoxy-2-oxoethylidene]-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]cyclopentyl]acetate C25H34O7 详情 详情
(XI) 37245 N-(3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-yl)-N-methylamine; 3-ethoxy-N-methyl-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-amine C10H16N2O2 详情 详情
(XII) 37246 (2R)-N-[(4R)-3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-yl]-2-methoxy-N-methyl-2-phenylethanamide C19H24N2O4 详情 详情
(XIII) 37247 (4R)-3-ethoxy-N-methyl-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-amine; N-[(4R)-3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-yl]-N-methylamine C10H16N2O2 详情 详情
(XIV) 37248 (4R)-4-(methylamino)-4,5,6,7-tetrahydro-1,2-benzisoxazol-3-ol C8H12N2O2 详情 详情
(XV) 11159 iodomethyl pivalate C6H11IO2 详情 详情
(XVI) 37249 ([(4R)-4-[(tert-butoxycarbonyl)(methyl)amino]-4,5,6,7-tetrahydro-1,2-benzisoxazol-3-yl]oxy)methyl pivalate C19H30N2O6 详情 详情

合成路线23

该中间体在本合成路线中的序号:

2-Pyrrolidinone (I) was protected as the N-Boc derivative (II) and then alkylated with 3-bromo-2-methylpropene (III) in the presence of LDA to yield (IV). Further alkylation of (IV) with tert-butyl bromoacetate gave the dialkylated pyrrolidinone (V). Catalytic hydrogenation of the 2-methylpropenyl substituent of (V) produced the racemic isobutyl analogue (VI), which was resolved by means of chiral HPLC. The desired (S)-enantiomer (VII) was deprotected by treatment with magnesium ethoxide, affording pyrrolidinone (VIII). Triflate (XI) was obtained from D-phenyllactic acid (IX) by formation of the methyl ester (X) upon treatment with iodomethane, followed by reaction with trifluoromethanesulfonic anhydride and pyridine. N-Alkylation of the pyrrolidinone (VIII) with triflate (XI) furnished adduct (XII), which was hydrolyzed to carboxylic acid (XIII) with methanolic NaOH. After activation of (XIII) with carbonyl diimidazole, coupling with methylamine gave rise to amide (XIV). Cleavage of the tert-butyl ester group of (XIV) employing trifluoroacetic acid produced carboxylic acid (XV). This was finally coupled with hydroxylamine using EDC and HOBt.

1 Jacobsen, E.J. (Pharmacia & Upjohn AB); Hydroxamic acid derivs. for use with the treatment of diseases related to connective tissue degradation. EP 0898562; JP 2000506163; US 5712300; WO 9732846 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
17430 2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate 5292-43-3 C6H11BrO2 详情 详情
(I) 27397 2-Pyrrolidinone 616-45-5 C4H7NO 详情 详情
(II) 40014 tert-butyl 2-oxo-1-pyrrolidinecarboxylate C9H15NO3 详情 详情
(III) 40015 3-bromo-2-methyl-1-propene 1458-98-6 C4H7Br 详情 详情
(IV) 40016 tert-butyl 3-(2-methyl-2-propenyl)-2-oxo-1-pyrrolidinecarboxylate C13H21NO3 详情 详情
(V) 40017 tert-butyl 3-[2-(tert-butoxy)-2-oxoethyl]-3-(2-methyl-2-propenyl)-2-oxo-1-pyrrolidinecarboxylate C19H31NO5 详情 详情
(VI) 40018 tert-butyl 3-[2-(tert-butoxy)-2-oxoethyl]-3-isobutyl-2-oxo-1-pyrrolidinecarboxylate C19H33NO5 详情 详情
(VII) 40019 tert-butyl (3S)-3-[2-(tert-butoxy)-2-oxoethyl]-3-isobutyl-2-oxo-1-pyrrolidinecarboxylate C19H33NO5 详情 详情
(VIII) 40020 tert-butyl 2-[(3S)-3-isobutyl-2-oxopyrrolidinyl]acetate C14H25NO3 详情 详情
(IX) 40026 (2R)-2-hydroxy-3-phenylpropionic acid 7326-19-4 C9H10O3 详情 详情
(X) 13878 methyl (2R)-2-hydroxy-3-phenylpropanoate C10H12O3 详情 详情
(XI) 40027 methyl (2R)-3-phenyl-2-[[(trifluoromethyl)sulfonyl]oxy]propanoate C11H11F3O5S 详情 详情
(XII) 40028 methyl (2S)-2-[(3S)-3-[2-(tert-butoxy)-2-oxoethyl]-3-isobutyl-2-oxopyrrolidinyl]-3-phenylpropanoate C24H35NO5 详情 详情
(XIII) 40029 (2S)-2-[(3S)-3-[2-(tert-butoxy)-2-oxoethyl]-3-isobutyl-2-oxopyrrolidinyl]-3-phenylpropionic acid C23H33NO5 详情 详情
(XIV) 40030 tert-butyl 2-[(3S)-1-[(1S)-1-benzyl-2-(methylamino)-2-oxoethyl]-3-isobutyl-2-oxopyrrolidinyl]acetate C24H36N2O4 详情 详情
(XV) 40031 2-[(3S)-1-[(1S)-1-benzyl-2-(methylamino)-2-oxoethyl]-3-isobutyl-2-oxopyrrolidinyl]acetic acid C20H28N2O4 详情 详情

合成路线24

该中间体在本合成路线中的序号:(IX)

The formylation of 3,5-dichloropyridine (I) with methyl formate (II), BuLi and DIEA in THF gives 3,5-dichloropyridine-4-carbaldehyde (III), which is treated with 4-bromophenol (IV) and potassium tert-butoxide in hot THF to yield the adduct (V). This compound, without isolation is cyclized with methyl 2-mercaptoacetate (VI) by means of Cs2CO3 to afford 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylic acid methyl ester (VII), which is hydrolyzed with LiOH in THF/water to provide the corresponding carboxylic acid (VIII). Finally, this compound is condensed with methylamine (IX) by means of EDC and HOBt in DMF to give the target amide. Alternatively, the target amide can also be obtained by direct reaction of methyl ester (VII) with methylamine (IX) in hot methanol in a sealed tube.

1 Zhu, G.-D.; et al.; Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxy)theino[2,3-c]pyridines with fine-tuning at C-2 carbamides. J Med Chem 2001, 44, 21, 3469.
2 Lartey, K.; Gunawardana, I.W.; Stout, D.M.; Bhatia, P.; Patel, M.V.; Staeger, M.A.; Boyd, S.A.; Mort, N.A.; Zhu, G.-D.; McCarty, C.M.; Stewart, A.O.; Arendsen, D.L.; Condroski, K.R.; Freeman, J.C. (Abbott Laboratories Inc.); Cell adhesion-inhibiting antiinflammatory cpds.. WO 9962908 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 35535 3,5-dichloropyridine 2457-47-8 C5H3Cl2N 详情 详情
(II) 45474 methyl formate 107-31-3 C2H4O2 详情 详情
(III) 35536 3,5-dichloroisonicotinaldehyde; 3,5-Dichloropyridine-4-carbaldehyde 136590-83-5 C6H3Cl2NO 详情 详情
(IV) 25313 4-bromophenol 106-41-2 C6H5BrO 详情 详情
(V) 52015 3-(4-bromophenoxy)-5-chloroisonicotinaldehyde C12H7BrClNO2 详情 详情
(VI) 18838 methyl 2-sulfanylacetate 2365-48-2 C3H6O2S 详情 详情
(VII) 52016 methyl 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylate C15H10BrNO3S 详情 详情
(VIII) 52017 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylic acid C14H8BrNO3S 详情 详情
(IX) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情

合成路线25

该中间体在本合成路线中的序号:(II)

The condensation of tert-butoxycarbonylproline (I) with methylamine (II), isovaleraldehyde (III) and ethyl isocyanoacetate (IV) in methanol gives Boc-Pro-Me-Leu-Gly-OEt (V), which is separated from its diastereoisomer by chromatography over silica gel. The reaction of (V) with ammonia in cold methanol yields the corresponding amide (VI). Finally this compound is deprotected by treatment with dry HCl in ethyl acetate

1 Blancafort, P.; Serradell, M.N.; Castaner, J.; Owen, R.T.; Pareptide. Drugs Fut 1979, 4, 11, 821.
2 Failli, A.; et al.; Synthetic MIF analoges. Part I:synthesis by four component condensation (4CC) and classical methods. Arzneim-Forsch 1977, 27, 12, 2286.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 16734 (2S)-1-(tert-butoxycarbonyl)tetrahydro-1H-pyrrole-2-carboxylic acid; N-alpha-t-BOC-L-proline; (2S)-1-(tert-butoxycarbonyl)-2-pyrrolidinecarboxylic acid C10H17NO4 详情 详情
(II) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(III) 26052 3-methylbutanal 590-86-3 C5H10O 详情 详情
(IV) 11877 Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate 105-56-6 C5H7NO2 详情 详情
(V) 60946 tert-butyl (2S)-2-{[((1R)-1-{[(2-ethoxy-2-oxoethyl)amino]carbonyl}-3-methylbutyl)(methyl)amino]carbonyl}-1-pyrrolidinecarboxylate C21H37N3O6 详情 详情
(VI) 60947 tert-butyl (2S)-2-{[((1R)-1-{[(2-amino-2-oxoethyl)amino]carbonyl}-3-methylbutyl)(methyl)amino]carbonyl}-1-pyrrolidinecarboxylate C19H34N4O5 详情 详情

合成路线26

该中间体在本合成路线中的序号:(V)

The condensation of 4-bromophenyl-3-pyridyl ketone (I) with ethyl bromoacetate (II) by means of Zn in refluxing benzene gives ethyl 3-hydroxy-3-(3-pyridyl)-3-(4-bromophenyl)propionate (III), which is reduced with LiAlH4 in refluxing ethyl ether yielding 1-(3-pyridyl)-1-(4-bromophenyl)propane-1,3-diol (IV). Finally this compound is treated first with PBr3 and HBr in refluxing acetone, and then with methylamine (V) at 110 C in a pressure vessel

1 Blancafort, P.; Serradell, M.N.; Castaner, J.; Sweetman, A.J.; Nomelidine. Drugs Fut 1979, 4, 12, 885.
2 Carlsson, P.A.E.; et al. (Astra Lakemedel AB); BE 835802; DD 122528; DE 2550005; FR 2291751; JP 7676278; NL 7513648; ZA 7506893 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 60939 (4-bromophenyl)(3-pyridinyl)methanone C12H8BrNO 详情 详情
(II) 16640 Ethyl 2-bromoacetate; Ethyl bromoacetate 105-36-2 C4H7BrO2 详情 详情
(III) 60940 ethyl 3-(4-bromophenyl)-3-hydroxy-3-(3-pyridinyl)propanoate C16H16BrNO3 详情 详情
(IV) 60941 1-(4-bromophenyl)-1-(3-pyridinyl)-1,3-propanediol C14H14BrNO2 详情 详情
(V) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情

合成路线27

该中间体在本合成路线中的序号:(V)

The condensation of 4-bromophenyl-3-pyridyl ketone (I) with ethyl bromoacetate (II) by means of Zn in refluxing benzene gives ethyl 3-hydroxy-3-(3-pyridyl)-3-(4-bromophenyl)propionate (III), which is converted into the corresponding methylamide (VI) by treatment with methylamine (V) in ethanol. This compound is reduced with NaBH4 in THF yielding 3-(3-pyridyl)-3-(4-bromophenyl)-3-hydroxy-N-methylpropylamine (VII), which is finally dehydrated by treatment with 50% H2SO4 at 110 C

1 Blancafort, P.; Serradell, M.N.; Castaner, J.; Sweetman, A.J.; Nomelidine. Drugs Fut 1979, 4, 12, 885.
2 Carlsson, P.A.E.; et al. (Astra Lakemedel AB); BE 835802; DD 122528; DE 2550005; FR 2291751; JP 7676278; NL 7513648; ZA 7506893 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 60939 (4-bromophenyl)(3-pyridinyl)methanone C12H8BrNO 详情 详情
(II) 16640 Ethyl 2-bromoacetate; Ethyl bromoacetate 105-36-2 C4H7BrO2 详情 详情
(III) 60940 ethyl 3-(4-bromophenyl)-3-hydroxy-3-(3-pyridinyl)propanoate C16H16BrNO3 详情 详情
(V) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(VI) 60942 3-(4-bromophenyl)-3-hydroxy-N-methyl-3-(3-pyridinyl)propanamide C15H15BrN2O2 详情 详情
(VII) 60943 1-(4-bromophenyl)-3-(methylamino)-1-(3-pyridinyl)-1-propanol C15H17BrN2O 详情 详情

合成路线28

该中间体在本合成路线中的序号:(VI)

Reductive cyclization of 6-fluoro-3-(2-nitroethyl)-1H-indole-4-carboxylic acid methyl ester (I) by means of Zn and HCl in methanol/water gives 8-fluoro-3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indol-6-one (II), which is brominated by means of Pyr/HBr/Br2 in THF/dichloromethane to afford the 2-bromo derivative (III). Condensation of the brominated compound (III) with 4-formylphenylboronic acid (IV) by means of Pd(PPh3)4 and Na2CO3 in refluxing H2O/ethanol/toluene provides 8-fluoro-2-(4-formylphenyl)-3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indol-6-one (V), which is finally reductocondensed with methylamine (VI) by means of NaBH4 (1). Scheme 1.

1 Webber, S.E., Thoresen, L.H., Tikhe, H., Canan-Koch, S.S. (Agouron Pharmaceuticals, Inc.; Cancer Research UK). Tricyclic inhibitors of poly(ADP-ribose) polymerases. CA 2360003, EP 1140936, JP 2002534523, US 6495541, WO 2000042040.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 65864 6-fluoro-3-(2-nitroethyl)-1H-indole-4-carboxylic acid methyl ester   C12H11FN2O4 详情 详情
(II) 65865 8-fluoro-3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indol-6-one   C11H9FN2O 详情 详情
(III) 65866 2-bromo-8-fluoro-3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indol-6-one   C11H8BrFN2O 详情 详情
(IV) 61564 4-Formylphenylboronic acid; 4-Formylbenzeneboronic acid; 4-Boronobenzaldehyde; Benzaldehyde-4-boronic acid; 4-Formylphenylboronic acid 87199-17-5 C7H7BO3 详情 详情
(V) 65867 8-fluoro-2-(4-formylphenyl)-3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indol-6-one   C18H13FN2O2 详情 详情
(VI) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情

合成路线29

该中间体在本合成路线中的序号:(II)

 

1 Pulla Reddy M.2007. Improved process for the preparation of ibandronate sodium. W0 2007013097[本专利为Natco Pharma Ltd(IN)所有]
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10847 Acrylonitrile 107-13-1 C3H3N 详情 详情
(II) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(III) 24278 3-(methylamino)propanenitrile 693-05-0 C4H8N2 详情 详情
(IV) 66461 3-(methyl(pentyl)amino)propanenitrile   C9H18N2 详情 详情
(V) 15769 3-[methyl(pentyl)amino]propionic acid C9H19NO2 详情 详情

合成路线30

该中间体在本合成路线中的序号:(XII)

Iodination of 3-(trifluoromethyl)-2-pyridinol (I) with NIS in acetonitrile/DMF at 80 °C gives 5-iodo-3-(trifluoromethyl)-2-pyridinol (II), which is treated with POCl3 in DMF at 110 °C under microwave to yield 2-chloro-5-iodo-3-(trifluoromethyl)pyridine (III). Condensation of iodide (III) with 4-methoxybenzylamine (IV) in the presence of Pd2dba3, xantphos and t-BuONa in refluxing toluene or using Pd(OAc)2, BINAP, Et3N and Cs2CO3 in toluene under microwave provides secondary amine (V), which is reacted with Zn(CN)2 in the presence of Pd2dba3 and dppf in DMF at 130 °C to obtain nitrile (VI). N-Deprotection of compound (VI) by means of TFA in CH2Cl2 affords 5-amino-3-(trifluoromethyl)pyridine-2-carbonitrile (VII), which is condensed with thiophosgene (VIII) in CHCl3/H2O to yield 5-isothiocyanato-3-(trifluoromethyl)pyridine-2-carbonitrile (IX). Finally, isothiocyanate (IX) is submitted to cyclocondensation with nitrile (X) in DMF at 80 °C under microwave, followed by treatment with HCl in refluxing MeOH .
Synthesis of intermediate (X): Condensation of 2,4-difluorobenzoyl chloride (XI) with methylamine (XII) in THF produces 2,4-difluoro-N-methylbenzamide (XIII), which is condensed with 4-methoxybenzylamine (IV) in acetonitrile (1, 3, 4) or DMSO at 190 °C under microwave (2) to give the secondary amine (XIV). N-Deprotection of compound (XIV) by means of TFA in CH2Cl2 provides 4-amino-2-fluoro-N-methylbenzamide (XV), which is finally condensed with cyclobutanone (XVI) and NaCN in AcOH at 80 °C . Alternatively, amino nitrile (X) is obtained by direct condensation of fluoride (XIII) with 1-aminocyclobutanecarbonitrile (XVII) (prepared by Strecker reaction of cyclobutanone (XVI) with NaCN, NH4Cl and NH3 in the presence of MgSO4) .

1 Jung, M.E., Sawyers, C.L., Ouk, S., Tran, C., Wongvipat, J. (University of California, Oakland). Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases. US 8802689; EP 2004181; US 2011003839; WO 2007126765; EP 2656842; EP 2656841; EP 2368550; JP 2009531439.
2 Ouerfelli, O., Dilhas, A., Yang, G., Zhao, H. (Sloan-Kettering Institute for Cancer Research). Synthesis of thiohydantoins. US 2013225821; US 8461343; WO 2008119015.
3 Jung, M.E., Sawyers, C.L., Ouk, S., Tran, C., Wongvipat, J. (University of California, Oakland). Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases. US 2013072511.
4 Jung, M.E., Sawyers, C.L., Ouk, S., Tran, C., Wongvipat, J. (University of California, Oakland). Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases. US 2013072511.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 67484 3-(trifluoromethyl)pyridin-2-ol   C6H4F3NO 详情 详情
(II) 67485 5-iodo-3-(trifluoromethyl)pyridin-2-ol   C6H3F3INO 详情 详情
(III) 67486 2-chloro-5-iodo-3-(trifluoromethyl)pyridine   C6H2ClF3IN 详情 详情
(IV) 15098 4-Methoxybenzylamine; (4-Methoxyphenyl)methanamine 2393-23-9 C8H11NO 详情 详情
(V) 67487 6-chloro-N-(4-methoxybenzyl)-5-(trifluoromethyl)pyridin-3-amine   C14H12ClF3N2O 详情 详情
(VI) 67488 5-((4-methoxybenzyl)amino)-3-(trifluoromethyl)picolinonitrile   C15H12F3N3O 详情 详情
(VII) 67489 5-amino-3-(trifluoromethyl)picolinonitrile   C7H4F3N3 详情 详情
(VIII) 67490 Thiophosgene;Thiocarbonyl chloride 463-71-8 CCl2S 详情 详情
(IX) 67491 5-isothiocyanato-3-(trifluoromethyl)picolinonitrile   C8H2F3N3S 详情 详情
(X) 67492 4-((1-cyanocyclobutyl)amino)-2-fluoro-N-methylbenzamide   C13H14FN3O 详情 详情
(XI) 67493 2,4-difluorobenzoyl chloride 72482-64-5 C7H3ClF2O 详情 详情
(XII) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(XIII) 67494 2,4-difluoro-N-methylbenzamide   C8H7F2NO 详情 详情
(XIV) 67495 2-fluoro-4-((4-methoxybenzyl)amino)-N-methylbenzamide   C16H17FN2O2 详情 详情
(XV) 67496 4-amino-2-fluoro-N-methylbenzamide   C8H9FN2O 详情 详情
(XVI) 26374 cyclobutanone 1191-95-3 C4H6O 详情 详情
(XVII) 67497 1-aminocyclobutanecarbonitrile   C5H8N2 详情 详情

合成路线31

该中间体在本合成路线中的序号:(XXIII)

Jones oxidation of 2-fluoro-4-methyl-1-nitrobenzene (XVIII) with CrO3 and H2SO4, followed by acetylation with Ac2O in AcOH yields the gemdiacetate (XIX), which by deacetylation with HCl in AcOH at 115 °C provides 3-fluoro-4-nitrobenzaldehyde (XX). Horner-Wadsworth-Emmons reaction of aldehyde (XX) with ethyl (diethoxyphosphoryl)acetate (XXI) using NaH in THF affords the unsaturated ester (XXII), which by fluoride substitution with methylamine (XXIII) in DMSO provides the nitro-aniline derivative (XXIVa) . Alternatively, condensation of 2,4-dichloro-1-nitrobenzene (XXV) with methylamine (XXIII) using Et3N in DMSO or THF yields 5-chloro-N-methyl-2-nitroaniline (XXVI), which is then subjected to Heck coupling with ethyl acrylate (XXVIIa), methyl acrylate (XXVIIb) or butyl acrylate (XXVIIa) in the presence of Pd(OAc)2, LiCl and DIEA in DMAc at 110 °C , or Pd2dba3, t-Bu3P and (c-Hex)2NMe at 110 °C to give the corresponding arylacrylates (XXIVa), (XXIVb) or (XXIVc). Reduction of the nitro group in compounds (XXIVa), (XXIVb) or (XXIVc) by means of SnCl2.2H2O in EtOH at 80 °C , H2 over Raney-Ni in toluene/MeOH or Na2S2O4 and K2CO3 in EtOH/H2O produces the corresponding diaminophenylacrylates (XXVIIIa) , (XXVIIIb) or (XXVIIIc) , which are finally condensed with 1-aminocyclo-butanecarboxylic acid hydrochloride (XXIX) in CH2Cl2 to provide the benzimidazole intermediates (IIIa) , (IIIb) or (XXX), the free base of intermediate (II) .
Similarly, intermediate (II) can be obtained by condensation of the diaminophenylacrylate (XXVIIIc) with N-Boc-1-aminocyclobutanecarboxylic acid (XXXI) using DCC in toluene, followed by N-deprotection and cyclization of the resulting amino amide (XXXII) with HCl in BuOH at 75 °C .

1 Boecher, W., Haefner, C., Kukolj, G. (Boehringer Ingelheim Pharma GmbH & Co. KG). Combination therapy for treating HCV infection. CN 103228278, EP 2621495, JP 2013540112, KR 2013116245, US 2012135949, WO 2012041771.
2 Brickl, R.-S., Chen, S., Chung, J. et al. (Boehringer Ingelheim Pharma GmbH & Co. KG). Solid state forms of a potent HCV inhibitor. CN 103153987, EP 2621921, JP 2013543495, KR 2013108326, US 2012122887, US 8598183, US 2014057928, WO 2012044520.
3 Mensa, F., Nehmiz, G. (Boehringer Ingelheim Pharma GmbH & Co. KG). Oral combination therapy for treating HCV infection in specific patient subgenotype populations. WO 2013147749.
4 Mensa, F. (Boehringer Ingelheim Pharma GmbH & Co. KG). Oral combination therapy for treating HCV infection in specific patient sub-population. WO 2013147750.
5 LaPlante, S.R., Boes, M., Brochu, C. et al. Conformation-based restrictions and scaffold replacements in the design of hepatitis C virus polymerase inhibitors. Discovery of deleobuvir (BI 207127). J Med Chem 2014, 57(5): 1845-54.
6 Tsantrizos, Y.S., Chabot, C., Beaulieu, P. et al. (Boehringer Ingelheim Pharma GmbH & Co. KG). Viral polymerase inhibitors. CN 102911161, CN 103304541, CN 103319464, CN 103333162, EP 1718608, EP 2626354, JP 2007523094, JP 2010195818, JP 2010280740, KR 2012091276, US 2005222236, US 8030309, WO 2005080388.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXIVa) 67786 (E)-ethyl 3-(3-(methylamino)-4-nitrophenyl)acrylate   C12H14N2O4 详情 详情
(XXIVb) 67787 (E)-methyl 3-(3-(methylamino)-4-nitrophenyl)acrylate   C11H12N2O4 详情 详情
(XXIVc) 67788 (E)-butyl 3-(3-(methylamino)-4-nitrophenyl)acrylate   C14H18N2O4 详情 详情
(XXVIIa) 10164 ethyl acrylate 140-88-5 C5H8O2 详情 详情
(XXVIIb) 14156 methyl acrylate 96-33-3 C4H6O2 详情 详情
(XXVIIc) 67789 butyl acrylate   C7H12O2 详情 详情
(XXVIIIa) 67791 (E)-ethyl 3-(4-amino-3-(methylamino)phenyl)acrylate   C12H16N2O2 详情 详情
(XXVIIIb) 67792 (E)-methyl 3-(4-amino-3-(methylamino)phenyl)acrylate   C11H14N2O2 详情 详情
(XXVIIIc) 67790 (E)-butyl 3-(4-amino-3-(methylamino)phenyl)acrylate C14H20N2O2 详情 详情
(IIIa) 67765 (E)-methyl 3-(2-(1-aminocyclobutyl)-1-methyl-1H-benzo[d]imidazol-6-yl)acrylate   C16H19N3O2 详情 详情
(IIIb) 67766 (E)-ethyl 3-(2-(1-aminocyclobutyl)-1-methyl-1H-benzo[d]imidazol-6-yl)acrylate   C17H21N3O2 详情 详情
(II) 67764 (E)-butyl 3-(2-(1-aminocyclobutyl)-1-methyl-1H-benzo[d]imidazol-6-yl)acrylate dihydrochloride   C19H25N3O2.2HCl 详情 详情
(XVIII) 39366 2-fluoro-4-methyl-1-nitrobenzene 446-34-4 C7H6FNO2 详情 详情
(XIX) 67783 (3-fluoro-4-nitrophenyl)methylene diacetate   C11H10FNO6 详情 详情
(XX) 67784 3-fluoro-4-nitrobenzaldehyde   C7H4FNO3 详情 详情
(XXI) 10019 Ethyl 2-(diethoxyphosphoryl)acetate; Triethyl phosphonoacetate 867-13-0 C8H17O5P 详情 详情
(XXII) 67785 (E)-ethyl 3-(3-fluoro-4-nitrophenyl)acrylate   C11H10FNO4 详情 详情
(XXIII) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(XXV) 21787 2,4-dichloro-1-nitrobenzene 611-06-3 C6H3Cl2NO2 详情 详情
(XXVI) 46715 5-chloro-N-methyl-2-nitroaniline; N-(5-chloro-2-nitrophenyl)-N-methylamine 35966-84-8 C7H7ClN2O2 详情 详情
(XXIX) 67793 1-aminocyclo-butanecarboxylic acid hydrochloride 98071-16-0 C5H9NO2.HCl 详情 详情
(XXX) 67794 (E)-butyl 3-(2-(1-aminocyclobutyl)-1-methyl-1H-benzo[d]imidazol-6-yl)acrylate   C19H25N3O2 详情 详情
(XXXI) 67795 1-((tert-butoxycarbonyl)amino)cyclobutanecarboxylic acid   C10H17NO4 详情 详情
(XXXII) 67796 (E)-butyl 3-(4-amino-3-(1-((tert-butoxycarbonyl)amino)-N-methylcyclobutanecarboxamido)phenyl)acrylate   C24H35N3O5 详情 详情

合成路线32

该中间体在本合成路线中的序号:(XX)

Uracil intermediate (I) is obtained as follows. Condensation of 2-fluoro-4-iodophenyl isocyanate (XIII) with cyclopropylamine (XIV) in Et2O , or alternatively reaction of 2-fluoro-4-iodoaniline (XV) with CDI in the presence of Et3N in DMF, followed by condensation with cyclopropylamine (XIV) affords disubstituted urea (XVI). Cyclization of urea (XVI) is treated with malonic acid (XVII) in the presence of AcCl in Ac2O at 60 °C affords the pyrimidine trione (XVIII), which is chlorinated using POCl3 in the presence of PhNMe2 and a catalytic amount of H2O at 90 °C to provide a mixture of 6-chloropyrimidine (XIX) and the corresponding regioisomer. Finally, chloropyrimidine (XIX) is treated with methylamine (XX) in EtOH at 80 °C .
In an alternative procedure, acylation of urea (XVI) with cyanoacetic acid (XXI) by means of MsCl in DMF yields the N-(cyanoacetyl)urea (XXII), which cyclizes in aqueous NaOH at 80 °C to yield the amino-pyrimidine derivative (XXIII). Condensation of amine (XXIII) with dimethylformamide dimethylacetal (XXIV) in DMF affords formamidine (XXV), which is finally reduced using NaBH4 in EtOH/t-BuOH .

2 Sakai, T., Kawasaki, H., Abe, H. et al. (Japan Tobacco, Inc.). 5-Amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido[2,3-d]pyrimidine derivatives and related compounds for the treatment of cancer. CN 101912400, EP 1761528, EP 1894932, EP 2298768, JP 2008201788, JP 2008501631, US 2006014768, US 7378423, US 2008312228, US 201024013, WO 2005121142.
1 Abe, H., Kikuchi, S., Hayakawa, K. et al. Discovery of a highly potent and selective MEK inhibitor: GSK1120212 (JTP-7407 DMSO solvate). ACS Med Chem Lett 2011, 2(4): 320.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 68359 1-(2-fluoro-4-iodophenyl)-3-cyclopropyl-6-(methylamino)uracil;3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-(methylamino)pyrimidine-2,4(1H,3H)-dione C14H13FIN3O2 详情 详情
(XIII) 68369 2-fluoro-4-iodophenyl isocyanate   C7H3FINO 详情 详情
(XIV) 12263 Cyclopropylamine; Cyclopropanamine 765-30-0 C3H7N 详情 详情
(XV) 63342 2-fluoro-4-iodoaniline; 2-fluoro-4-iodophenylamine 29632-74-4 C6H5FIN 详情 详情
(XVI) 68370 1-cyclopropyl-3-(2-fluoro-4-iodophenyl)urea   C10H10FIN2O 详情 详情
(XVII) 12963 Malonic acid 141-82-2 C3H4O4 详情 详情
(XVIII) 68371 1-cyclopropyl-3-(2-fluoro-4-iodophenyl)pyrimidine-2,4,6(1H,3H,5H)-trione   C13H10FIN2O3 详情 详情
(XIX) 68372 6-chloro-3-cyclopropyl-1-(2-fluoro-4-iodophenyl)pyrimidine-2,4(1H,3H)-dione   C13H9ClFIN2O2 详情 详情
(XX) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(XXI) 12591 Cyanoacetic Acid; 2-Cyanoacetic acid 372-09-8 C3H3NO2 详情 详情
(XXII) 68373 2-cyano-N-cyclopropyl-N-((2-fluoro-4-iodophenyl)carbamoyl)acetamide   C13H11FIN3O2 详情 详情
(XXIII) 68374 6-amino-3-cyclopropyl-1-(2-fluoro-4-iodophenyl)pyrimidine-2,4(1H,3H)-dione   C13H11FIN3O2 详情 详情
(XXIV) 11984 N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal 4637-24-5 C5H13NO2 详情 详情
(XXV) 68375 (E)-N'-(1-cyclopropyl-3-(2-fluoro-4-iodophenyl)-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-N,N-dimethylformimidamide   C16H16FIN4O2 详情 详情
Extended Information